FDA’s Vision on PRO/eCOA Collection for RWE: Timing and Methods Explained

Watch our on-demand webinar now where our panel of experts unlock insights on how the FDA view the collection of patient-reported outcomes (PROs) for real-world evidence. Our presenters delve into critical FDA comments & guidance on PRO data collection methods, timing, and quality, while keeping participant experience as priority number one.